Our Team
Josh Magid
Josh Magid is a managing director in the firm’s strategic advisory practice and focuses on healthcare services and technology.
Since joining Evercore in 2016, Mr. Magid has advised public and private healthcare companies on mergers & acquisitions and capital raising, as well as financial sponsors on investing in healthcare services and technology. Notable engagements include advising athenahealth on its sale to Hellman & Friedman and Bain; Centene on its acquisition of WellCare Health Plans and sales of Magellan Rx and U.S. Medical Management; Nestlé on its sale of Nestlé Skin Health to EQT and ADIA; special committee of Inovalon on the sale to Nordic; Humana on its acquisitions of Kindred and Curo Health Services; Stratus Video on its sale to AMN; and Intermedix on its sale to R1 RCM.
Prior to joining Evercore, Mr. Magid was an associate at JSB-Partners, a boutique advisory firm.
Mr. Magid graduated from Brandeis University with a B.A. in economics and an M.A. in international economics and earned his MBA in health care management from University of Pennsylvania’s Wharton School.